Simultaneous Determination of Ginsenoside Rg1, Re, Rd, Rb1 and Ophiopogonin D in Rat Plasma by Liquid Chromatography/electrospray Ionization Mass Spectrometric Method and Its Application to Pharmacokinetic Study of 'SHENMAI' Injection
Overview
Chemistry
Authors
Affiliations
A sensitive and rapid liquid chromatography-mass spectrometric method for the simultaneous determination of ginsenoside Rg1, Re, Rd, Rb1 and ophiopogonin D in rat plasma was developed and validated. Chromatographic separation was performed on a C18 column using a step gradient program with the mobile phase of 0.5mmol/L ammonium chloride solution and acetonitrile. The analytes and I.S. were detected using an electrospray negative ionization mass spectrometry in the selected ion monitoring (SIM) mode. The method was linear over the investigated concentration range with a good correlation coefficient higher than 0.997. The lower limits of detection (LLOD) of these analytes were all lower than 2.0ng/mL. The intra- and inter-day precisions were all no more than 7.5% and accuracies were within the range of 97.5-107.0%. The validated method was successfully applied to investigate the pharmacokinetics of ginsenoside Rg1, Re, Rd, Rb1 and ophiopogonin D in rat after intravenous administration of 'SHENMAI' injection.
Ophiopogonin D: review of pharmacological activity.
Chen K, Wang S, Lei H, Liu X Front Pharmacol. 2024; 15:1401627.
PMID: 39101149 PMC: 11295246. DOI: 10.3389/fphar.2024.1401627.
Bampidis V, Azimonti G, Bastos M, Christensen H, Durjava M, Kouba M EFSA J. 2024; 22(4):e8730.
PMID: 38591023 PMC: 11000137. DOI: 10.2903/j.efsa.2024.8730.
Quality monitoring of Shenmai injection by HPLC pharmacodynamic fingerprinting.
Yang G, Li S, Sun X, Lv Y, Huang H BMC Chem. 2023; 17(1):28.
PMID: 36966333 PMC: 10039686. DOI: 10.1186/s13065-023-00920-7.
He Y, Hu C, Liu S, Xu M, Liang G, Du D Drug Des Devel Ther. 2022; 16:2479-2495.
PMID: 35941928 PMC: 9356589. DOI: 10.2147/DDDT.S364352.
Pharmacological Properties of Ginsenoside Re.
Gao X, Liu G, Zhang J, Wang L, Xu C, Yan Z Front Pharmacol. 2022; 13:754191.
PMID: 35462899 PMC: 9019721. DOI: 10.3389/fphar.2022.754191.